ALNYLAM PHARMACEUTICALS, INC.: accounts_receivable

Value{"amount": 146587000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"}
Period (as of 2021-06-30)
Statuscurrent
EntityALNYLAM PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001178670-21-000024
Retrieved: 2026-08-19T11:51:50.761763+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001178670/accounts-receivable/2021-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/a2bbd7c4-b1b2-4b21-a017-7a3a2d9ba6e3

History